OncoguardĀ® Liver
Use
The OncoguardĀ® Liver test is a novel approach aimed at the early-stage detection of hepatocellular carcinoma (HCC), the most common type of liver cancer. Early detection of HCC is crucial as it significantly improves outcomes, allowing curative treatments to be applied at a stage when they are more effective. The test utilizes a unique panel of DNA and protein markers selected for their sensitivity and specificity, providing reliable results that can empower treatment decisions and potentially increase long-term survival for patients at risk of HCC.
Special Instructions
Not provided.
Limitations
While the OncoguardĀ® Liver test offers advanced sensitivity and specificity, it is important to be aware that no test can guarantee 100% accuracy. False positives and negatives can occur, and results should be interpreted by healthcare professionals in the context of the patient's overall clinical picture. The effectiveness of the test depends on the patient's adherence to regular surveillance schedules as recommended by healthcare providers.
Methodology
Other
Biomarkers
No genes
GeneUnknown protein
Protein
Result Turnaround Time
0 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided
Collection Instructions
The OncoguardĀ® Liver test is performed with a single blood draw, making the process straightforward and convenient for patients.
Other tests from different labs that may be relevant